Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Reexamination Certificate
2007-03-06
2007-03-06
Kim, John (Department: 1723)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
C424S602000, C424S606000, C424S663000, C424S678000, C424S679000, C424S680000, C424S681000, C424S682000, C514S822000, C210S647000
Reexamination Certificate
active
10742137
ABSTRACT:
A multi-part substitution infusion fluid for an extracorporeal blood treatment and methods for using same are provided. Generally, the multi-part substitution fluid comprises a first solution composed of electrolites but without divalent cations and a second solution comprising divalent cations. Another embodiment includes a third solution comprising a matching citrate/citric acid anticoagulant. The described methods of using the multi-part substitution infusion fluids significantly reduce risks associated with various extracorporeal blood treatments.
REFERENCES:
patent: 3962075 (1976-06-01), Fialkoff et al.
patent: 4308255 (1981-12-01), Raj et al.
patent: 4336881 (1982-06-01), Babb et al.
patent: 4339433 (1982-07-01), Kartinos et al.
patent: 4489535 (1984-12-01), Veltman
patent: 4574085 (1986-03-01), Dolkart et al.
patent: 4604379 (1986-08-01), Twardowski et al.
patent: 4649050 (1987-03-01), Veech
patent: 4663166 (1987-05-01), Veech
patent: 4668400 (1987-05-01), Veech
patent: 4690772 (1987-09-01), Tell et al.
patent: 4879280 (1989-11-01), Seyffart et al.
patent: 4880629 (1989-11-01), Okamoto et al.
patent: 4886789 (1989-12-01), Milner
patent: 4889634 (1989-12-01), El-Rashidy
patent: 4980374 (1990-12-01), Steudle et al.
patent: 5011826 (1991-04-01), Steudle et al.
patent: 5032615 (1991-07-01), Ward et al.
patent: 5100677 (1992-03-01), Veech
patent: 5178763 (1993-01-01), Delaunay
patent: 5192459 (1993-03-01), Tell et al.
patent: 5211643 (1993-05-01), Reinhardt et al.
patent: 5252213 (1993-10-01), Ahmad et al.
patent: 5296242 (1994-03-01), Zander
patent: 5436232 (1995-07-01), Forster et al.
patent: 5589197 (1996-12-01), Shockley et al.
patent: 5597805 (1997-01-01), Breborowicz et al.
patent: 5616248 (1997-04-01), Schal
patent: 5626880 (1997-05-01), Inoue et al.
patent: 5629025 (1997-05-01), Shockley et al.
patent: 5631025 (1997-05-01), Shockley et al.
patent: 5670176 (1997-09-01), Martis et al.
patent: 5674527 (1997-10-01), Inoue et al.
patent: 5698230 (1997-12-01), Martis et al.
patent: 5728681 (1998-03-01), Kido et al.
patent: 5827820 (1998-10-01), duMoulin et al.
patent: 5945129 (1999-08-01), Knerr et al.
patent: 5945449 (1999-08-01), Purcell et al.
patent: 5955450 (1999-09-01), Breborowicz et al.
patent: 6017942 (2000-01-01), Bergstrom
patent: 6020007 (2000-02-01), Veech
patent: 6077836 (2000-06-01), Milner
patent: 6083935 (2000-07-01), Wu et al.
patent: 6156797 (2000-12-01), Kubo et al.
patent: 6214802 (2001-04-01), Nakamura et al.
patent: 6248726 (2001-06-01), Alsop et al.
patent: 6251437 (2001-06-01), Fischbach
patent: 6277556 (2001-08-01), Grode et al.
patent: 6277815 (2001-08-01), Knerr
patent: 6306836 (2001-10-01), Martis et al.
patent: 6309673 (2001-10-01), Duponchelle et al.
patent: 6610206 (2003-08-01), Callan et al.
patent: 6743191 (2004-06-01), Chang
patent: 2001/0003794 (2001-06-01), Landry et al.
patent: 3224823 (1984-01-01), None
patent: 4122754 (1993-01-01), None
patent: 4211455 (1993-12-01), None
patent: 76355 (1983-04-01), None
patent: 86553 (1983-08-01), None
patent: 115911 (1984-08-01), None
patent: 153164 (1985-08-01), None
patent: 399918 (1990-11-01), None
patent: 417478 (1991-03-01), None
patent: 456928 (1991-11-01), None
patent: 602014 (1994-06-01), None
patent: 821951 (1998-02-01), None
patent: 2084484 (1982-04-01), None
patent: 3 56010109 (1981-02-01), None
patent: 56 128711 (1981-10-01), None
patent: 01 242531 (1989-09-01), None
patent: 4 03038527 (1991-02-01), None
patent: 04 069341 (1992-03-01), None
patent: 4 05105633 (1993-04-01), None
patent: 4 06105906 (1994-04-01), None
patent: 4 06178802 (1994-06-01), None
patent: 4 06237991 (1994-08-01), None
patent: 4 06245995 (1994-09-01), None
patent: 4 06335527 (1994-12-01), None
patent: 4 06335528 (1994-12-01), None
patent: 4 07059846 (1995-03-01), None
patent: 4 08092071 (1996-04-01), None
patent: 4 08131542 (1996-05-01), None
patent: 4 08164199 (1996-06-01), None
patent: 4 08169836 (1996-07-01), None
patent: 4 10087478 (1998-04-01), None
patent: 4 11114054 (1999-04-01), None
patent: 4 11197240 (1999-07-01), None
patent: 11279051 (1999-10-01), None
patent: 4 11343230 (1999-12-01), None
patent: 0 2000037452 (2000-02-01), None
patent: 0 2000051348 (2000-02-01), None
patent: 0 2000072658 (2000-03-01), None
patent: 0 2000140095 (2000-05-01), None
patent: 0 2000245826 (2000-09-01), None
patent: 0 2000288083 (2000-10-01), None
patent: 0 2001054570 (2001-02-01), None
patent: WO 90/15612 (1990-12-01), None
patent: WO 90/15612 (1990-12-01), None
patent: WO 91/10457 (1991-07-01), None
patent: WO 93/19792 (1993-10-01), None
patent: WO 93/24108 (1993-12-01), None
patent: WO 96/01118 (1996-01-01), None
patent: WO 97/30694 (1997-08-01), None
patent: WO 98/10745 (1998-03-01), None
patent: WO 98/29151 (1998-07-01), None
patent: WO 99/01144 (1999-01-01), None
patent: WO 99/09953 (1999-03-01), None
patent: WO 99/17762 (1999-04-01), None
patent: WO 99/20249 (1999-04-01), None
patent: WO 00/33853 (2000-06-01), None
Ashton, D.N., et al.; “Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis”: ANNA Journal, (Jun. 1991); 18 (3) 263-7, 329; XP000978120; Abstract, p. 265.
Macias, W.L.; “Choice of replacement fluid/dialysate anion in continuous renal replacement therapy”; American Journal of Kidney Diseases, (1996) 28/5 Suppl. 3 (S15-S20); XP000978102; Abstract; p. S15-p. S16; p. S19.
Ono, K., et al.; “Glucose in the dialyzate does not reduce the free amino acid loss during routine hemodialysis of non-fasting patients”; Clinical Nephrology, (1984) 21/2 (106-109); Coden: CLNHBI; XP000856986; Abstract.
Palsson, R., et al.; “Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding”; Kidney International, (May 1999) 55 (5); 1991-7; XP000978115; Abstract.
Sieberth, H.G.; [“Composition of the rinsing water for extracorporeal hemodialysis in acute and chronic renal failure”]; Zusammensetzung des Waschwassers fur die extracorporale Hamodialyse der akuten und chronischen Niereninsuffizienz; Medizinische Technik, (1974) 94/2 (28-32); Coden: Meteav, XP000856013; Abstract; p. 31, col. 2; Table 1, Abstract.
Van Stone, J.C.; “Individualization of the dialysate prescription in chronic hemodialysis”; Dialysis and Transplantation, (1994) 23/11 (624-625+628-635); XP000856008; Abstract the Whole Document, p. 634.
Chang Peter C.
Lannoy Jean-Michel
Edwards Lifesciences Corporation
Kim John
Yadav Rajiv
LandOfFree
Multi-part substitution infusion fluids and matching... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-part substitution infusion fluids and matching..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-part substitution infusion fluids and matching... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3755844